Fig. 4
From: Treatment with senicapoc in a porcine model of acute respiratory distress syndrome
Administration of senicapoc reduces levels of BALF white blood cells and neutrophils. Cell counts of a plasma white blood cells at 6h; b plasma neutrophils at 6h; c plasma lymphocytes at 6h; d BALF white blood cells; e BALF neutrophils and f BALF lymphocytes. Data are presented as mean ± SD. *P < 0.05 for senicapoc against vehicle. Vehicle, n = 9 and senicapoc, n = 8. BALF, bronchoalveolar lavage fluid; WBC, white blood cells